Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
about
Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression dataAssessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative ColitisThe role of integrin antagonists in the treatment of inflammatory bowel disease.Unintended Immunological Consequences of Biologic Therapy.Emerging aspects of leukocyte migration.Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis.Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease.
P2860
Q28533874-2B130D14-6FFE-4684-A63A-B8C0C62E1A4EQ28597396-5C213874-0F22-4307-9C02-BBF8FAEE1CB4Q38257410-539AC61F-D4C5-42FD-9C9C-DD6D4C810699Q38871098-CE14DED6-5959-44F8-BE20-8F80EA4D0E02Q44801255-0DBB7952-6FB5-4D7E-BE33-79C8069EF288Q47409340-F4147E20-4CDC-4259-A45C-DEE587E95970Q52618987-D0680DA9-22D8-424C-A091-8FAC859E0246
P2860
Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
@en
type
label
Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
@en
prefLabel
Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
@en
P2093
P2860
P1476
Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
@en
P2093
Nilanjan Ghosh
Rituparna Chaki
Subhash C Mandal
P2860
P304
P356
10.3109/08830185.2012.690794
P577
2012-10-01T00:00:00Z